Cargando…

Intra-Arterial Delivery of Idarubicin in Two Patients with Glioblastoma

There is no effective treatment for recurrent glioblastoma (GB) when temozolomide-based radiochemotherapy fails. In theory, intra-arterial (IA) delivery of cytotoxic agents could achieve higher drug concentrations in tumors compared to intravenous injection. Moreover, choosing a highly lipid-soluble...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chehimi, Mohamad, Boone, Mathieu, Chivot, Cyril, Deramond, Hervé, Constans, Jean-Marc, Ly, Mony Chenda, Chauffert, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043287/ https://www.ncbi.nlm.nih.gov/pubmed/27721775 http://dx.doi.org/10.1159/000448654

Ejemplares similares

ERK1/2 signaling regulates the immune microenvironment and macrophage recruitment in glioblastoma
por: Lailler, Claire, et al.
Publicado: (2019)

Combining genomic analyses with tumour-derived slice cultures for the characterization of an EGFR-activating kinase mutation in a case of glioblastoma
por: Loriguet, Lea, et al.
Publicado: (2018)

Thrombotic Microangiopathy Revealing Bone Metastases from an Ethmoid Sinus Carcinoma
por: Morisse, Mony Chenda, et al.
Publicado: (2016)

Temozolomide and Bevacizumab Induction before Chemoradiotherapy in Patients with Bulky Glioblastoma and/or with Severe Neurological Impairment
por: Darmon, Ilan, et al.
Publicado: (2017)

Sustained Response of a Clivus Chordoma to Erlotinib after Imatinib Failure
por: Houessinon, Aline, et al.
Publicado: (2015)

Expression Analysis of α5 Integrin Subunit Reveals Its Upregulation as a Negative Prognostic Biomarker for Glioblastoma
por: Etienne-Selloum, Nelly, et al.
Publicado: (2021)

Confocal microscopy of idarubicin localisation.
por: Manfait, M., et al.
Publicado: (1997)

Confocal microscopy of idarubicin localisation - reply
por: Duffy, P, et al.
Publicado: (1997)

Reassessing the Role of Intra-Arterial Drug Delivery for Glioblastoma Multiforme Treatment
por: Ellis, Jason A., et al.
Publicado: (2015)

Upfront Bevacizumab and Temozolomide or Fotemustine before Radiotherapy for Patients with Glioblastoma and Severe Neurological Impairment at Diagnosis
por: Bihan, Celina, et al.
Publicado: (2012)

Transarterial Chemoembolization of Hepatocellular Carcinoma with Idarubicin-Loaded Tandem Drug-Eluting Embolics
por: Guiu, Boris, et al.
Publicado: (2019)

High Response Rate to Carboplatin-Paclitaxel-Cetuximab and Pembrolizumab in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
por: Chauffert, Bruno, et al.
Publicado: (2023)

The induction of apoptosis by daunorubicin and idarubicin in human trisomic and diabetic fibroblasts
por: Dragojew, Sylwia, et al.
Publicado: (2008)

Idarubicin-bromelain combination sensitizes cancer cells to conventional chemotherapy
por: Taşkın, Abdullah, et al.
Publicado: (2019)

Idarubicin–Gold Complex: From Crystal Growth to Gold Nanoparticles
por: Barbey, Carole, et al.
Publicado: (2021)

Analysis to Estimate Genetic Variations in the Idarubicin-Resistant Derivative MOLT-3
por: Komiyama, Tomoyoshi, et al.
Publicado: (2016)

Insights into idarubicin antimicrobial activity against methicillin-resistant Staphylococcus aureus
por: She, Pengfei, et al.
Publicado: (2020)

Idarubicin vs doxorubicin in transarterial chemoembolization of intermediate stage hepatocellular carcinoma
por: Roth, Gaël Stéphane, et al.
Publicado: (2020)

Treatment outcome of doxorubicin versus idarubicin in adult acute myeloid leukemia
por: Sherif, Hemat Afifi, et al.
Publicado: (2021)

Correction to “Idarubicin–Gold Complex: From Crystal Growth to Gold Nanoparticles”
por: Barbey, Carole, et al.
Publicado: (2022)

Congenital afibrinogenemia: a case report of a spontaneous hepatic hematoma
por: Malaquin, Stephanie, et al.
Publicado: (2016)

Two Cases of Fatal Encephalopathy Related to Ifosfamide: An Adverse Role of Aprepitant?
por: Séjourné, Alice, et al.
Publicado: (2014)

Externally triggered smart drug delivery system encapsulating idarubicin shows superior kinetics and enhances tumoral drug uptake and response
por: Lu, Tao, et al.
Publicado: (2021)

Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer
por: Guardiola, Emmanuel, et al.
Publicado: (2009)

Idarubicin Plus Behenoyl Cytarabine and 6-thioguanine Compares Favorably with Idarubicin Plus Cytarabine-based Regimen for Children with Previously Untreated Acute Myeloid Leukemia: 10-Year Retrospective, Multicenter Study in Korea
por: Lee, Dae Hyoung, et al.
Publicado: (2010)

Confocal microscopy of idarubicin localisation in sensitive and multidrug-resistant bladder cancer cell lines.
por: Duffy, P. M., et al.
Publicado: (1996)

Methotrexate plus idarubicin improves outcome of patients with primary central nervous system lymphoma
por: Fan, Ni, et al.
Publicado: (2017)

Carbon-based ruthenium nanomaterial-based electroanalytical sensors for the detection of anticancer drug Idarubicin
por: Kaya, S. Irem, et al.
Publicado: (2020)

Idarubicin combats abiraterone and enzalutamide resistance in prostate cells via targeting XPA protein
por: Zhang, Ying, et al.
Publicado: (2022)

Designing Biodegradable Wafers Based on Poly(L-lactide-co-glycolide) and Poly(glycolide-co-ε-caprolactone) for the Prolonged and Local Release of Idarubicin for the Therapy of Glioblastoma Multiforme
por: Turek, Artur, et al.
Publicado: (2020)

Intra-arterial delivery of mesenchymal stem cells
por: Watanabe, Mitsuyoshi, et al.
Publicado: (2016)

Intra ventricular glioblastoma
por: Mandour, Cherkaoui, et al.
Publicado: (2014)

Improvement of Induction Remission Rate by Modifying the Dose of Idarubicin for Relapsed Childhood Acute Lymphoblastic Leukemia
por: Yoon, Jong Hyung, et al.
Publicado: (2009)

The Clinical Outcome of FLAG Chemotherapy without Idarubicin in Patients with Relapsed or Refractory Acute Myeloid Leukemia
por: Lee, Se Ryeon, et al.
Publicado: (2009)

Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy
por: Rodríguez-Macías, Gabriela, et al.
Publicado: (2023)

Efficacy and toxicity of midostaurin with idarubicin and cytarabine induction in FLT3-mutated acute myeloid leukemia
por: Lee, Julia S., et al.
Publicado: (2023)

Cerebral Blood and CSF Flow Patterns in Patients Diagnosed for Cerebral Venous Thrombosis - An Observational Study
por: ElSankari, Souraya, et al.
Publicado: (2012)

Idarubicinol myelotoxicity: a comparison of in vitro data with clinical outcome in patients treated with high-dose idarubicin
por: Corsini, C, et al.
Publicado: (2000)

Ara-C, Idarubicine and Gentuzumab Ozogamicin (AIM) as Salvage Treatment in Advanced Acute Myeloid Leukemia Patients
por: Capria, Saveria, et al.
Publicado: (2012)

Combined treatment of rituximab, idarubicin, dexamethasone, cytarabine, methotrexate with radiotherapy for primary central nervous system lymphoma
por: Zhao, Defeng, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3rv33fb0f0t4m76u7l3srgkj1t